Kinase inhibitors

Details Kinase inhibitors Kinase inhibitors

2007-08-21

2007-08-21

Wilson, James O. (Department: 1624)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Having -c-, wherein x is chalcogen, bonded directly to...

C514S359000, C514S360000, C544S224000, C544S336000, C548S100000, C548S125000, C548S452000, C548S469000, C548S517000

Reexamination Certificate

active

10472156

ABSTRACT:
A compound of the general formula:or pharmaceutically acceptable salts, hydrates, solvates, crystal forms or diastereomers thereof is described. A method of treating protein kinase-associated disease states using the compound of formula I is also described.

REFERENCES:
patent: WO 02/060492 (2000-08-01), None
patent: WO 00/62778 (2000-10-01), None
patent: WO-04/004730 (2004-01-01), None
patent: WO-04/085388 (2004-10-01), None
Harpur et al., Oncogene (1992) 7:1347-1353.
International Search Report mailed on Aug. 5, 2003, for PCT patent application No. PCT/AU03/00628 filed on May 23, 2003, 3 pages.
Kozma et al., EMBO Journal (1986) 7(1):147-154.
Sadowski et al., Molecular and Cellular Biology (1986) 6 (12):4396-4408.
Spiotto and Chung, The Prostate (2000) 42:88-98.
Wilks and Kurban, Oncogene (1988) 3:289-294.
Wilks et al., Molecular and Cellular Biology (1991) 11(4):2057-2065.
Supplementary European Search Report for EP 03722065.4, mailed on Jun. 6, 2006, 3 pages.

Affiliated with

Also associated with

Rating

Kinase inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Kinase inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Kinase inhibitors will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3858931